Wire · operational-macro
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 September 2026 · Fusion42 review
Sanara MedTech has proposed a merger with MiMedx Group, where Sanara shareholders will receive cash and MiMedx stock, resulting in MiMedx owning the majority of the combined company. The merger aims to create a larger platform in wound care and regenerative medicine, pending shareholder approval.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Your wound care or regenerative medicine venture faces a changed competitive set as MiMedx consolidates with Sanara, shrinking the independent players. Reassess partners and customers who may now be under one roof and track the combined firm's new go-to-market approach.
◆ Coverage
1 source · 5 Sep 2026
◆ Related on Wire
◆ Topics